Nalaganje...
Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways
There is a current requirement for novel therapeutic strategies for the treatment of hematopoietic tumors. Residual tumor cells are the main origin of tumor relapse. The aim of this study was to eliminate the residual tumor cells of hematopoietic tumors. Cytokine-induced killer (CIK) cells are used...
Shranjeno v:
| izdano v: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353788/ https://ncbi.nlm.nih.gov/pubmed/25780412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2264 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|